Does deficiency of phosphoinositide 3-kinase enhancer protect mice from diet-induced obesity and insulin resistance?
Our results suggest that PIKE-A is implicated in obesity and associated diabetes development by negatively regulating AMPK activity.
Oral antibiotic treatment of a first AOM episode occurring during infancy does not affect the number of AOM recurrences and AOM-related health care utilization later in life. This information can be used when weighing the pros and cons of various AOM treatment options.